2025 ICD-10-CM code F13
This code represents disorders related to the use of sedatives, hypnotics, or anxiolytics.
Medical necessity for treatment of SHA-related disorders is established by documenting the clinically significant impairment or distress caused by the substance use. The documentation must support the diagnosis and demonstrate the need for intervention to address the identified condition.
Clinicians diagnose SHA-related disorders by considering the patient's history, physical examination findings, reported symptoms, and social and personal behavior patterns. Treatment may include counseling, behavioral therapies, support groups, ongoing care, monitoring, and residential treatment programs, potentially incorporating specific medications. Emergency overdose treatment may involve naloxone and oxygen support.
- Mental, Behavioral and Neurodevelopmental disorders (F01-F99)
- Mental and behavioral disorders due to psychoactive substance use (F10-F19)
In simple words: This code refers to problems related to the use of medications like sleeping pills and tranquilizers.These problems can range from misuse to addiction and can have significant physical and mental health effects.
Sedative, hypnotic, or anxiolytic (SHA) related disorders encompass conditions arising from the abuse of or dependence on these substances.These substances depress the central nervous system, similar to alcohol.The disorders include intoxication, withdrawal, and SHA-use disorder.Symptoms may include mood swings, impaired speech, memory loss, disturbed gait, lack of coordination, anxiety, depression, irritability, delusions, and hallucinations.Severe cases, especially involving combined use with alcohol, can lead to coma or death.Elderly individuals using SHAs may experience increased falls and confusion. Diagnosis involves patient history, symptom assessment, and inquiries into personal and social behavior, along with a physical examination.
Example 1: A patient presents with slurred speech, uncoordinated movements, and impaired memory after taking an excessive dose of a prescribed sleeping medication. This scenario is indicative of sedative, hypnotic, or anxiolytic intoxication (F13)., An individual experiences anxiety, hand tremors, and insomnia after abruptly stopping long-term use of benzodiazepines, suggesting a diagnosis of sedative, hypnotic, or anxiolytic withdrawal (F13)., A patient exhibits a pattern of escalating use of anti-anxiety medication despite experiencing negative social consequences and acknowledges a persistent desire to reduce use, meeting criteria for sedative, hypnotic, or anxiolytic use disorder (F13).
Documentation should include the type of substance used, current severity of the disorder, presence of any complications, and the patient’s remission status. Detailed information about the patient's history, signs, symptoms, personal and social behavior, and physical examination findings are crucial for accurate coding.
- Specialties:Addiction medicine, psychiatry, psychology, emergency medicine, internal medicine, family medicine
- Place of Service:Inpatient Hospital, Residential Substance Abuse Treatment Facility, Outpatient Hospital, Office, Emergency Room - Hospital, Telehealth Provided in Patient’s Home, Telehealth Provided Other than in Patient’s Home